Stay updated on IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page history shows a new revision label from v3.3.3 to v3.3.4, which is a minor backend update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T10:49:40.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Added a footer notice 'Revision: v3.3.3'. Removed the 'HHS Vulnerability Disclosure' link and the 'Revision: v3.3.2' reference.
    Difference
    0.1%
    Check dated 2025-12-17T20:14:11.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The history now includes additions for Contacts/Locations and Study Status. A deletion on 2024-11-14 removes a prior data item from the record.
    Difference
    0.3%
    Check dated 2025-12-03T13:39:12.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 has been added to the history, and the previous v3.2.0 entry has been removed.
    Difference
    0.1%
    Check dated 2025-11-26T13:51:19.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    Removed the site-wide operating status notice about government funding. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-19T08:32:17.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    Version history indicates multiple entries updating Study Status and Contacts/Locations for NCT05013229, reflecting ongoing status and site information changes.
    Difference
    0.1%
    Check dated 2025-10-28T05:11:44.000Z thumbnail image

Stay in the know with updates to IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.